Gardeniae Fructus derived natural small molecule-based carbon dots promoting activation and aggregation of platelets

Jiawen Zhang1, Yong Hou2, Xueshan Xu3

  • 1Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China.

Effective and prompt hemostasis poses a formidable challenge currently, especially for tissue injury-induced endogenous hemorrhage. Carbonic herbs originated from traditional Chinese medicine (TCM) have been historically utilized in the treatment of endogenous hemorrhages, but the underlying active ingredients and hemostatic mechanism still remain largely unexplored. Study on carbon dots (CDs) prepared by main small molecule components from TCM is of great significance for unravelling the mechanism of action of carbonic herbs. Gardeniae Fructus is a classical TCM which widely used for hemostasis after carbonization. Given that geniposide is one of main small molecule components of it, geniposide-carbon dots (Gen-CDs) are developed using modified hydrothermal method and considered as the key pharmacological agents responsible for the hemostatic efficacy of carbonized Gardeniae Fructus (CGF). Undergoing repeated dehydration and condensation, Gen-CDs having abundant functional groups were obtained from geniposide, exhibiting superior water solubility and bioavailability. The mouse liver injury model, tail amputation model, and rat blood-heat hemorrhage (BHH) syndrome model were all employed to confirm the excellent hemostatic activity of Gen-CDs on exogenous hemorrhage. The in vitro and vivo experiments had indicated that Gen-CDs could effectively promote platelet activation and aggregation. Overall, the successful preparation of Gen-CDs with effective and prompt hemostatic performance could provide a new perspective for elucidating the substantial basis and mechanism of carbonic herbs.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.7K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
943
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
454